Page last updated: 2024-10-20

pyrazinamide and Conus Medullaris Syndrome

pyrazinamide has been researched along with Conus Medullaris Syndrome in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bozzola, E1
Bozzola, M1
Magistrelli, A1
Calcaterra, V1
Larizza, D1
Lancella, L1
Villani, A1
Chacko, AG1
Moorthy, RK1
Chandy, MJ1

Other Studies

2 other studies available for pyrazinamide and Conus Medullaris Syndrome

ArticleYear
Paediatric tubercular spinal abscess involving the dorsal, lumbar and sacral regions and causing spinal cord compression.
    Le infezioni in medicina, 2013, Volume: 21, Issue:3

    Topics: Adolescent; Antitubercular Agents; Drug Therapy, Combination; Epidural Abscess; Humans; Isoniazid; L

2013
The transpedicular approach in the management of thoracic spine tuberculosis: a short-term follow up study.
    Spine, 2004, Sep-01, Volume: 29, Issue:17

    Topics: Abscess; Adolescent; Adult; Aged; Antitubercular Agents; Braces; Combined Modality Therapy; Curettag

2004